News

Schlieren/Abingdon - The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the University of Zurich. The tests carried out via this platform allow specific cancer markers to be quantified in clinical trials.

Lugano - The newly inaugurated Dagorà Lifestyle Innovation Hub in Lugano is set to become an epicenter for creativity, research and technological innovation. The building houses over 15 companies and the Lifestyle Tech Competence Center across 1,700 square meters.

Switzerland is one of Google’s most important research locations in the world. Here’s an interview with Jennifer Wadsworth, Research Coordinator at the AI Center ETH Zurich, and Behshad Behzadi, Vice President of Engineering at Google Cloud in Zurich, about how excellence in academic research and entrepreneurial innovation are combining in the age of AI.

Zurich - The second EthereumZuri.ch conference will celebrate Ethereum's 10th anniversary. Since it was founded, the Greater Zurich Area has established itself as a global hub for the blockchain industry. Hundreds of participants will attend the conference, which will take place from April 5 to 7 at the University of Zurich.

Cadempino/Bridgewater - Zambon Biotech has obtained an exclusive license to seek regulatory approval for and market a Parkinson’s drug produced by U.S. pharmaceutical company Amneal. The novel oral formulation of an existing medicine is currently being reviewed by the U.S. regulatory authority.

Zurich - A research group from the University of Zurich (UZH) has discovered that the risk of a cerebral hemorrhage increases in stroke patients whose brains are resupplied with blood too quickly after the blood clot has been removed. This happens when vascular bridges between neighboring arterial trees are blocked.

Zurich/Minneapolis - Sherpany is being acquired by Datasite. In so doing, the company from Minneapolis is expanding its product portfolio for strategic transaction projects with the addition of Sherpany’s board-level meeting management software.

Zurich/Zollikon - Squirro and Adnovum from the canton of Zurich are joining forces to develop the next generation of artificial intelligence (AI). Adnovum plans to use Squirro's technology to improve its digital solutions. The goal is to put clients from diverse industries at the forefront of generative AI.

Zurich - A team from the University of Zurich (UZH) has developed an innovative cell culture model for nerve cells. This shows that there is a correlation between a misregulated protein and the degeneration of nerve cells in two types of neurodegenerative disease.